Equity · Healthcare
ORKA
Oruka Therapeutics, Inc. · NasdaqGM
The line runs $87 on 1 July through $94 on 16 September, on a scale from $80 to $120. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ORKA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 37 sessions over that window: $87 on 1 July 2026 through $94 on 16 September 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 16, 2026
ORKA insider trades
Showing the 12 most recent of 16 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
ORKA reported financials
ORKA reported net income of −$105.4M for the fiscal year ended 31 Dec 2025.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
ORKA earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
ORKA institutional holders
6 of the 45 institutional funds we track reported a ORKA position for the quarter ended 30 Jun 2026 — a combined $262.1M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
ORKA fails-to-deliver
On 27 Aug 2026, 3,356 shares of ORKA failed to deliver (about $334K) — the latest of 4 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data